{"acquisitions":[],"changes":[],"country":"GB","description":"Trimtech Therapeutics develops targeted protein degraders, branded TRIMTACs and TRIMGLUEs, that selectively remove disease-causing proteins to treat CNS and inflammatory disorders. It is built for patients with intractable disease driven by toxic protein buildup. Its programs use TRIM21, a widely expressed but underused ubiquitin ligase.","domain":"trimtech.bio","employees":null,"founded":2024,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":52.197585,"lng":0.139154,"location":"Cambridge, UK","multiples":[],"name":"Trimtech Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":31000000,"connectionsAmong":[],"currency":"USD","date":"2025-03-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"trimtech-bio-2025-03-15-seed","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"trimtech-bio","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"trimtech.bio","retrievedAt":"2026-05-08","status":"self-reported","url":"https://trimtech.bio"},{"fact":"description","publisher":"trimtech.bio","retrievedAt":"2026-05-08","status":"self-reported","url":"https://trimtech.bio"}],"stage":"seed","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":31000000,"traction":[],"updatedAt":"2026-05-08","valuations":[]}